Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Vertex Pharmaceuticals Incorporated
Woman and Man Max 99 years
Vertex Pharmaceuticals Incorporated
Update Il y a 4 ans
A randomized, double-blind, placebo-controlled, multiple dose study of VX-809 to evaluate safety, pharmacokinetics, and pharmacodynamics of VX-809 in cystic fibrosis subjects homozygous for the deltaF508-CFTR gene mutation
To evaluate the safety and tolerability of VX-809 in CF patients who are homozygous for the DeltaF508-CFTR mutation
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Vertex Pharmaceuticals Incorporated
Update Il y a 4 ans
Study to compare the effects of VX-787 with placebo against influenza
The primary objective of the study is to determine the effect of oral administration of VX 787 administered post-inoculation on the AUC of viral titers quantified by nasal swab cell culture in a human...
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
1
2
3
4